<DOC>
	<DOC>NCT00833430</DOC>
	<brief_summary>Long-term follow-up of IDE patients for publication</brief_summary>
	<brief_title>Avascular Necrosis (AVN) Long-Term Follow-up</brief_title>
	<detailed_description>This device (Hedrocel AVN Intervention Implant) was approved via 510(k) on April 15, 2005. One site was left open to follow patients to 5 year follow-up for publication of device survivorship.</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Shock</mesh_term>
	<criteria>Patient qualifies for core decompression based on physical exam No history of core decompression Patient is willing and able to provide written informed consent Patient has been diagnosed as Stage 0, III, IV, V or VI using the Steinberg/UPenn staging system. Patient's BMI is &gt;40 Patient is mentally compromised Patient has neurological condition in ipsilateral or contralateral limb, which affect lower limb function The patient has had a proximal femoral osteotomy or internal fixation in the affected hip. The patient has undergone previous treatment for AVN Previous hip conditions Patient's bone stock is insufficient Patient has diagnosed systemic disease Patient is a pregnant female Patient is unable or unwilling to attend postop followup visits Patient has received investigational drug within the previous 6 months or an investigational device within the last 12 months Patient has an active or latent infection Patient has metal sensitivity Patient is a prisoner</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>AVN</keyword>
	<keyword>Femoral Head Collapse</keyword>
</DOC>